Abstract
In addition to the critical role of endoscopic ultrasound in gastrointestinal malignancies, endobronchial ultrasound (EBUS) may compliment the evaluation and treatment of esophageal and nonesophageal malignancies. Using both convex and radial probe ultrasound, the mediastinum and parenchymal lung lesions may be evaluated to more precisely determine the extent of disease compared with traditional strategies. EBUS may also provide therapeutic advantages by assisting in stent placement or treating parenchymal metastases. This article aims to discuss the benefits derived from using EBUS in the diagnosis, staging, and treatment of gastrointestinal malignancies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
